Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network. The foundation is establishing a scientific and industry advisory board that will convene experts in genetics, clinical care, research, and ethics to implement this new initiative.

“For people with Parkinson’s, genetic tests are either not available, not affordable, and not covered by health insurance or offered in tandem with genetic counseling,” said John L. Lehr, CEO of the Parkinson’s Foundation. “We look to solve that by offering genetic testing, coupled with counseling in a clinical setting where doctors and patients can work together to best manage the disease.”

Three key objectives of the Parkinson’s Foundation’s Genetic Initiative are:

  1. Accelerate clinical trials: Recognizing that most people with Parkinson’s do not know their genetic status or eligibility for advanced clinical trials, the Parkinson’s Foundation will offer genetic testing at select Centers of Excellence. This initial strategy will assist in the recruitment for clinical trials of individuals with specific gene variants in LRRK2 (leucine-rich repeat kinase 2)Mutations in this gene are the most common cause of inherited Parkinson’s. Researchers have identified more than 100 LRRK2 gene mutations that increase the risk of developing PD. It is particularly common in people of Ashkenazi Jewish, North African Arab Berber and Basque descent, and variants have also been found in Chinese and Japanese populations. This gene is also known as PARK8, denoting its link to Parkinson’s disease and the order in which it was found to have a connection to PD (8th). and GBA.
  2. Unlock the potential of genetics for improved Parkinson’s care and research: Enrollment in this initiative will create the largest, active Parkinson’s disease database linking genetic status to clinical status.
  3. Empower people living with Parkinson’s: Genetic data offer insights into disease progression and symptom severity that may potentially influence clinical care and treatment decisions. 

The foundation will establish a repository of genetic data through its Parkinson’s Outcomes Project, the largest, ongoing clinical study of Parkinson’s disease to date.  The study has collected patient information on more than 10,000 individuals with Parkinson’s. The addition of genetic information to the clinical outcomes data will increase scientific knowledge and understanding of the impact of genetics in Parkinson’s.

“What makes this initiative unique is its novel approach of offering genetic testing for relevant Parkinson’s-related genes in an easily accessible, clinical environment through our network,” said James Beck, PhD, Chief Scientific Officer at the Parkinson’s Foundation. “We expect that this will accelerate enrollment in clinical trials for the next generation of treatments and help facilitate the use of genetic information to improve care and expand research.”

The Parkinson’s Foundation leads efforts to identify and disseminate new treatments and improved care through its Center of Excellence network. Each center is staffed by specialists in Parkinson’s disease treatment, delivering the highest standard of care currently available. The network includes 42 academic medical centers around the world, including 28 in the United States.

“Most people with Parkinson’s do not know their genetic status and therefore do not know if they will be eligible for the next generation of clinical trials,” said Jon Stoessl, MD, chair of the Parkinson’s Foundation Scientific Advisory Board. “With this initiative, a patient’s genetic status will be available to help inform clinical decision-making from the start, as well as track and analyze outcomes over time in a more comprehensive fashion.”

While experts estimate that 10 percent to 15 percent of all Parkinson’s cases are genetic forms of the disease, they also believe the disease is caused by a complex interaction of genetic and environmental factors. Parkinson’s Foundation-supported scientists are currently working to identify the underlying genetic mechanisms of the disease – a critical step to developing new therapies and treatments.

The foundation will convene members of its Scientific Advisory Board, patient advocates, industry and academic partners, and Center of Excellence directors in May 2018 at the annual Parkinson’s Foundation Center Leadership Conference in New Jersey. The first series of sites for implementation of the Genetic Initiative will be announced in the fall of 2018.

The idea for the Genetic Initiative sparked from discussions with Parkinson’s Foundation Scientific Advisory Board Member Roy Alcalay, MD, MS, an expert in the genetics of Parkinson’s disease and assistant professor of neurology at Columbia University, a Parkinson’s Foundation Center of Excellence.

###

About the Parkinson’s Foundation 
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease 
Affecting nearly one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

Tuesday, March 6, 2018
Parkinson's Disease Foundation Mobilizes Community to Address Unmet Needs of Women Living with Parkinson’s
Wednesday, September 16, 2015

The Parkinson's Disease Foundation® (PDF®) is pleased to launch its Women and PD Initiative, the first national coordinated effort dedicated to improving the health and well-being of women living with Parkinson’s disease. The initiative launches this week with a three-day conference in Florham Park, NJ.

Parkinson's Disease Foundation Highlights Under-recognized Aspects of Disease with New Online Educational Series
Tuesday, September 15, 2015

The Parkinson's Disease Foundation® (PDF®) is pleased to announce the launch of its latest series of PD ExpertBriefings — six free online seminars designed to shed light on under-recognized aspects of Parkinson's disease. The series, presented by leaders in Parkinson's research and care, begins today, Tuesday, September 15 at 1:00 PM ET.

PDF-Funded Research Paves the Way to Phase III Drug Trial
Wednesday, September 2, 2015

The Parkinson’s Disease Foundation (PDF) is pleased to announce that research initially launched with PDF funding will be tested in a phase III clinical trial A research study in humans that aims to test a new intervention – this could be a drug, surgery or therapy like exercise or diet guidelines – to make sure it is effective a

The National Parkinson Foundation’s Medical Director Publishes New Book on Breakthrough Therapies for Parkinson’s Disease
Monday, August 31, 2015

Sequel to 2013 Bestseller, “Parkinson’s Treatment: 10 Secrets to a Happier Life”

PDF Mourns the Passing of Oliver Sacks
Sunday, August 30, 2015

The Parkinson’s Disease Foundation  (PDF) mourns the loss of neurologist and friend, Oliver Sacks, M.D., (pictured at left), who passed away on August 30th. 

The National Parkinson Foundation Welcomes New Board Member
Friday, August 21, 2015

MIAMI — The National Parkinson Foundation (NPF) announced the election of a new member to its Board of Directors: Dr. Guido Goldman.

The National Parkinson Foundation Launches New and Improved Parkinson.org
Monday, August 3, 2015

Premier website for the Parkinson's disease community

MIAMI — The National Parkinson Foundation announces today the official launch of a redesigned website, www.parkinson.org, devoted to increasing awareness and understanding of Parkinson's disease by offering free resources to people diagnosed with the disease and their families.

NPF Funds Community Research
Monday, June 29, 2015

The National Parkinson Foundation’s Moving Day® Fall 2014 Walks Fund Nearly $1 Million in Parkinson’s Programs

Community Grants Awarded in Atlanta, Boston, Chicago, Los Angeles, Miami and North Carolina

NPF Study Finds that Regular Exercise Can Slow Decline in Quality of Life
Wednesday, June 17, 2015

Data from the Parkinson’s Outcomes Project Presented at the 19th International Congress of Parkinson’s Disease and Movement Disorders

PDF Congratulates New NINDS Director Walter J. Koroshetz, M.D.
Tuesday, June 16, 2015

The Parkinson's Disease Foundation congratulates Walter J. Koroshetz, M.D., on being selected as the Director of the National Institute of Neurological Disorders and Stroke (NINDS). In this role, Dr. Koroshetz assumes oversight of a $1.6 billion budget for scientific research into neurological diseases, including Parkinson’s disease.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.